| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |